首页 | 本学科首页   官方微博 | 高级检索  
     


Best practice BioBanking of human heart tissue
Authors:Sean Lal  Amy Li  David Allen  Paul D. Allen  Paul Bannon  Tim Cartmill  Roger Cooke  Alan Farnsworth  Anne Keogh  Cristobal dos Remedios
Affiliation:1. Bosch Institute, Discipline of Anatomy & Histology (F13), Sydney Heart Bank, University of Sydney, Sydney, 2006, Australia
2. School of Veterinary Medicine, Department of Molecular Bioscience, University of California Davis, 1089 Veterinary Medicine Drive, Davis, CA, 95616, USA
3. Baird Institute, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Australia
4. 70 Araluen Drive, Killcare, 2357, Australia
5. Department of Biochemistry and Biophysics, University of California San Francisco, 16th & 3rd Streets, San Francisco, CA, 94117, USA
6. Heart Transplant Unit, Xavier 4, St Vincent’s Hospital, Victoria Street, Darlinghurst, 2010, Australia
Abstract:
This review provides a guide to researchers who wish to establish a biobank. It also gives practical advice to investigators seeking access to samples of healthy or diseased human hearts. We begin with a brief history of the Sydney Heart Bank (SHB) from when it began in 1989, including the pivotal role played by the late Victor Chang. We discuss our standard operating procedures for tissue collection which include cryopreservation and the quality assurance needed to maintain the long-term molecular and cellular integrity of the samples. The SHB now contains about 16,000 heart samples derived from over 450 patients who underwent isotopic heart transplant procedures and from over 100 healthy organ donors. These enable us to provide samples from a wide range of categories of heart failure. So far, we have delivered heart samples to more than 50 laboratories over two decades, and we answer their most frequently asked questions. Other SHB services include the development of tissue microarrays (TMA). These enable end users to perform preliminary examinations of the expression and localisation of target molecules in diseased or aging donor hearts, all in a single section of the TMA. Finally, the processes involved in managing tissue requests from external users and logistics considerations for the shipment of human tissue are discussed in detail.

Electronic supplementary material

The online version of this article (doi:10.1007/s12551-015-0182-6) contains supplementary material, which is available to authorized users.
Keywords:BioBanking   Human heart tissue   Sydney Heart Bank   Heart failure   Healthy donor tissue
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号